Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Walgreens Boots Alliance Inc    

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Active Flu Season Boosts Walgreen's January Sales

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/05/2013 | 07:36pm CEST

Walgreen Co. (>> Walgreen Company) posted its first monthly same-store sales gain in a year in January, aided by an active flu season and firmer prescription orders stemming from the resolution of a contract dispute with a major pharmacy-benefits manager.

The 3.7% increase in same-store sales in January came above the projected 1.5% increase, according to analysts surveyed by Thomson Reuters.

Results last year were hurt by a rate contract dispute with pharmacy-benefits manager Express Scripts Holding Co. (>> Express Scripts Holding Co) that led millions to transfer their prescriptions to rival pharmacies. But since Walgreen and Express Scripts entered a new multiyear agreement that began in September, millions have returned to the fold.

The loss of the Express Scripts customers, as well as higher demand for lower-priced generic drugs, hurt Walgreen's same-store sales throughout 2012. In 2012, January's same-store sales dropped 4.6%.

Walgreen has also successfully courted some customers it had lost in the dispute and hopes to win back more, gains executives expect will be reflected in many of 2013's monthly sales reports. In January, pharmacy sales grew 8.7% and same-store pharmacy sales increased 6.2%, compared with an expected 2.4% jump. Prescriptions filled at comparable stores soared 14%.

Overall, total sales in January grew 6.3% to $6.15 billion from a year ago. Front-end sales were up 1.3%, while same-store front-end sales slid 0.4%, compared with expectations of a 0.5% drop.

Drugstore front-end sales have been helped by a nasty flu season, bolstering traffic and demand for prescriptions and over-the-counter treatments. Walgreen, which provides more flu vaccines in the U.S. than any other retailer, said it has administered 6.9 million flu vaccines so far this season, far above last year's 5.5 million.

But drugstore-retailer results have been stung by increasing demand for generic drugs, which Walgreen said hurt January's pharmacy same-store sales by six percentage points. Strong demand for those drugs products a mixed effect because copycat drugs carry higher margins than branded products but command lower prices, hurting same-store sales.

Last week, Rite Aid Corp. (>> Rite Aid Corporation) reported January same-store sales were up 0.3%, as a very active flu season helped offset the pressure from generics. CVS Caremark Corp. (>> CVS Caremark Corporation), which doesn't report monthly sales data, has already warned same-store sales in the first quarter would be lower. The company's full fourth-quarter results are due on Wednesday.

Walgreen's shares were inactive at $40.01 in premarket trading.

Write to John Kell at john.kell@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on WALGREENS BOOTS ALLIANCE I
09/26 WALGREENS BOOTS ALLIANCE : Charles R. Walgreen III, Former Walgreen Co. Chairman..
09/24 WALGREENS BOOTS ALLIANCE : PT Lowered to $102.00 at Cowen and Company (WBA)
09/22 WALGREENS BOOTS ALLIANCE : Foyston Gordon Payne Inc buys $18,986,378 stake in Wa..
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/22 RITE AID : 2Q profit drops on higher costs, revenue rises
09/20 STOCKS IN THE SPOTLIGHT : Dollar General Corporation (DG), Walgreens Boots Allia..
09/19 WALGREENS : Launches Skin Care Platform Providing Convenient Access to Dermatolo..
09/19 WALGREENS BOOTS ALLIANCE : Ngam Advisors buys $31,600,802 stake in Walgreens Boo..
09/19 WALGREENS BOOTS ALLIANCE : Gibraltar Capital Management Lowers stake in Walgreen..
09/19 WALGREENS BOOTS ALLIANCE : Shelton Capital Management buys $8,241,386 stake in W..
More news
Sector news : Drug Retailers - NEC
09/23DJRITE AID : Business Watch -- WSJ
09/22DJRITE AID : Same-Store Sales Fall Amid Generics Pressure
09/15 MCKESSON : German antitrust watchdog raids drugs distributors
09/09DJWALGREENS BOOTS ALLIANCE : To Divest Additional Stores -- WSJ
09/08DJWALGREENS BOOTS ALLIANCE : to Divest Additional Stores for Pending Rite Aid Tie-..
More sector news : Drug Retailers - NEC
Advertisement
Financials ($)
Sales 2016 117 879 M
EBIT 2016 6 968 M
Net income 2016 4 030 M
Debt 2016 10 410 M
Yield 2016 1,78%
P/E ratio 2016 21,34
P/E ratio 2017 17,38
EV / Sales 2016 0,83x
EV / Sales 2017 0,80x
Capitalization 87 321 M
More Financials
Chart WALGREENS BOOTS ALLIANCE I
Duration : Period :
Walgreens Boots Alliance I Technical Analysis Chart | US9314221097 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 92,3 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefano Pessina Executive Vice Chairman & Chief Executive Officer
James A. Skinner Executive Chairman
Ornella Barra Co-Chief Operating Officer
Alexander W. Gourlay Co-Chief Operating Officer
George Rollo Fairweather Global Chief Financial Officer & Executive VP
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
WALGREENS BOOTS ALLIAN..-0.07%87 321
CVS HEALTH CORP-8.03%95 874
WALGREENS BOOTS ALLIAN..-5.26%87 321
EXPRESS SCRIPTS HOLDIN..-19.20%44 512
MCKESSON CORPORATION-16.25%37 281
CARDINAL HEALTH INC-13.88%24 598
More Results